IDEAS home Printed from https://ideas.repec.org/a/epw/pharma/v2y2022i3id750.html

Assessment of the effects of an aqueous extract of the leaves, flowers, and seeds of Crotalaria retusa L (Fabaceae) on the glycemia in rats

Author

Listed:
  • Bi Lane Adrien Goh

    (Jean Lorougnon Guede University, Côte d'Ivoire)

  • Goore Guy Charles Gole Nanti

    (Jean Lorougnon Guede University, Côte d'Ivoire)

  • Stanislas Ouga Zahoui

    (Felix Houphouët-Boigny University, Côte d'Ivoire)

  • Semi Anthelme Nene-Bi

    (Felix Houphouët-Boigny University, Côte d'Ivoire)

  • Flavien Traore

    (Felix Houphouët-Boigny University, Côte d'Ivoire)

Abstract

The aim of this study was to evaluate the effects of an aqueous extract of Crotalaria retusa L (Fabaceae) (EACr) on glycemia in Wistar rats, to contribute to the valorization of plants used in traditional medicine for the improvement of people’s health. A phytochemical screening and pharmacological study of the aqueous extract of Crotalaria retusa L (Fabaceae) on glycemia in rats, were carried out. The administration of the substances in animals was made orally. The qualitative phytochemical study carried out with the aqueous extract of the leaves, the flowers, and the pods of Crotalaria retusa L (Fabaceae) made to highlight the presence of polyphenols, flavonoids, catechic, and gallic tannins, quinonic compounds, alkaloids, sterols, and polyterpenes. This extract showed hypoglycemic activity in the normoglycemic animals, treated with the dose of 1000 mg/kg BW with a percentage of reduction of the glycemia of 21.04%. After an overload of glucose, EACr (1000 mg/kg BW) and the glibenclamide (10-2g/kg BW) showed better antihyperglycemic activity in the rats post-treated, with respective percentages of reduction of 41.90 and 50.39%. EACr has hypoglycemic and antihyperglycemic properties which would be probably related to the presence of alkaloids, tannins, and flavonoids. These compounds, generally recognized for their hypoglycemic and antihyperglycemic effects, confer to this extract similar properties to those of certain insulin-secretors. These results support the use of this plant for the treatment of diabetes in traditional medicine and bring a scientific base.

Suggested Citation

Handle: RePEc:epw:pharma:v:2:y:2022:i:3:id:750
DOI: 10.24018/ejpharma.2022.2.3.50
as

Download full text from publisher

File URL: https://eu-opensci.org/index.php/pharma/article/view/750
File Function: Abstract page
Download Restriction: no

File URL: https://eu-opensci.org/index.php/pharma/article/download/750/305
File Function: Full text
Download Restriction: no

File URL: https://libkey.io/10.24018/ejpharma.2022.2.3.50?utm_source=ideas
LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
---><---

More about this item

Keywords

;
;
;
;

Statistics

Access and download statistics

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:pharma:v:2:y:2022:i:3:id:750. See general information about how to correct material in RePEc.

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

We have no bibliographic references for this item. You can help adding them by using this form .

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support Team (email available below). General contact details of provider: https://eu-opensci.org/index.php/pharma .

Please note that corrections may take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.